1. A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women. (September 2020) Authors: Tsai, Meng-shan; Chang, Shu-Han; Kuo, Wen-Hung; Kuo, Ching-Hua; Li, Szu-Yi; Wang, Ming-Yang; Chang, Dwan-Ying; Lu, Yen-Shen; Huang, Chiun-Sheng; Cheng, Ann-Lii; Lin, Ching-Hung; Chen, Pau-Chung Journal: Environment international Issue: Volume 142(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment. Issue 1 (December 2016) Authors: Liu, Ko-Jiunn; Chao, Tsu-Yi; Chang, Jang-Yang; Cheng, Ann-Lii; Ch'ang, Hui-Ju; Kao, Woei-Yau; Wu, Yu-Chen; Yu, Wei-Lan; Chung, Tsai-Rong; Whang-Peng, Jacqueline Journal: Journal of biomedical science Issue: Volume 23:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer. (5th January 2018) Authors: Chen, Tom Wei-Wu; Yeh, Dah-Cherng; Chao, Tsu-Yi; Lin, Ching-Hung; Chow, Louis Wing-Cheong; Chang, Dwan-Ying; Hsieh, Yao-Yu; Huang, Shu-Min; Cheng, Ann-Lii; Lu, Yen-Shen; Consortium, Taiwan Breast Cancer Journal: Japanese journal of clinical oncology Issue: Volume 48:Number 3(2018) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer. Issue 1 (December 2016) Authors: Chen, Bang-Bin; Lu, Yen-Shen; Lin, Ching-Hung; Chen, Wei-Wu; Wu, Pei-Fang; Hsu, Chao-Yu; Yu, Chih-Wei; Wei, Shwu-Yuan; Cheng, Ann-Lii; Shih, Tiffany Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240. (September 2021) Authors: Vogel, Arndt; Merle, Philippe; Verslype, Chris; Finn, Richard S.; Zhu, Andrew X.; Cheng, Ann-Lii; Chan, Stephen Lam; Yau, Thomas; Ryoo, Baek-Yeol; Knox, Jennifer; Daniele, Bruno; Qin, Shukui; Wei, Ziwen; Miteva, Yanna; Malhotra, Usha; Siegel, Abby B.; Kudo, Masatoshi Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients. (October 2021) Authors: Chen, I-Chun; Hu, Fu-Chang; Lin, Ching-Hung; Huang, Shu-Min; Chang, Dwan-Ying; Cheng, Ann-Lii; Lu, Yen-Shen Journal: Breast Issue: Volume 59(2021) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation. Issue 9 (2nd September 2015) Authors: Tsai, Hui-Jen; Shih, Neng-Yao; Kuo, Sung-Hsin; Cheng, Ann-Lii; Lin, Hui-You; Chen, Tsai-Yun; Chang, Kung-Chao; Lin, Sheng-Fung; Chang, Jeffrey S.; Chen, Li-Tzong Journal: Leukemia & lymphoma Issue: Volume 56:Issue 9(2015:Sep.) Page Start: 2674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cabozantinib after prior checkpoint inhibitor therapy in patients with solid tumors: A systematic literature review. (November 2022) Authors: Graham, Jeffrey; Vogel, Arndt; Cheng, Ann-Lii; Bjarnason, Georg A.; Neal, Joel W. Journal: Cancer treatment reviews Issue: Volume 110(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial. Issue 8 (August 2022) Authors: Kelley, Robin Kate; Rimassa, Lorenza; Cheng, Ann-Lii; Kaseb, Ahmed; Qin, Shukui; Zhu, Andrew X; Chan, Stephen L; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philipp... Journal: Lancet oncology Issue: Volume 23:Issue 8(2022) Page Start: 995 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer. (May 2020) Authors: Yang, Wen-Chi; Hsu, Feng-Ming; Chen, Yu-Hsuan; Shih, Jin-Yuan; Yu, Chong-Jen; Lin, Zhong-Zhe; Lu, Szu-Huai; Yang, James Chih-Hsin; Cheng, Ann-Lii; Kuo, Sung-Hsin Journal: Clinical and translational radiation oncology Issue: Volume 22(2020) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗